AMS to participate in upcoming investor conferences in November and December

AMS to participate in upcoming investor conferences in November and December

Winsford, UK: Advanced Medical Solutions Group plc (AIM:AMS), the innovative tissue healing medical device company delivering high-performing, cost-effective solutions for better patient outcomes, today announces that the Group will be participating in the following investor conferences in November and December:

• Investec UK CEO Conference, London

Date: 11 November 2025

Format: One-on-one and group investor meetings

• Berenberg European Conference, Windsor

Date: 4 December 2025

Format: One-on-one and group investor meetings

- End -

For further information, please visit www.admedsol.com or contact:

About Advanced Medical Solutions Group plc – see www.admedsol.com

AMS is an innovative tissue healing medical device company delivering high-performing, cost-effective solutions that match or surpass market leaders, clinically, technically, and commercially. From adhesives and sealants, to biosurgical devices and sutures, AMS’s products offer superior usability, quality and design. AMS’s strength lies in combining advanced material science with applicator device design and development, in collaboration with surgeons and Key Opinion Leaders, creating differentiated devices that improve patient outcomes without compromising quality or affordability.

AMS’s scalable, resilient business model is built on disciplined execution, portfolio focus, and capital efficiency. Its diversified product and geographic mix mitigates volatility, ensuring consistent performance even when individual segments fluctuate. Following its acquisition of Peters Surgical, AMS is unlocking operational and commercial synergies, accelerating its U.S. and international expansion, and increasing the percentage of sales made through its direct sales teams. With surgical products driving the lion’s share of group revenues and a clear growth trajectory, AMS is positioned for scalable growth, margin improvement, and long-term value creation.